Sign in

CIK 0001661181

  • Accelerated filer

Organogenesis Holdings Inc.

Sign in to watch
Ticker
ORGO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-575-0775
Business address
85 DAN ROAD, CANTON, MA, 02021
Former names
Avista Healthcare Public Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-04-22 Tamaroff Joshua Alexander Director Grant or award +18,564 18,564
2020-04-22 Leibowitz Arthur S Director Grant or award +18,564 23,564
2020-04-22 MACKIE WAYNE D Director Grant or award +18,564 118,564
2020-04-22 Freedman Lori VP and General Counsel Grant or award +26,918 26,918
2020-04-22 Freedman Lori VP and General Counsel Grant or award · Stock Option (Right to Buy) +177,310 177,310
2020-04-22 Bilbo Patrick Chief Operating Officer Grant or award +34,035 155,835
2020-04-22 Bilbo Patrick Chief Operating Officer Grant or award · Stock Option (Right to Buy) +224,185 224,185
2020-04-22 Grow Brian Chief Commercial Officer Grant or award +32,488 35,767
2020-04-22 Grow Brian Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +213,995 213,995
2020-04-22 Cunningham Timothy M. Chief Financial Officer Grant or award +27,847 27,847
2020-04-22 Cunningham Timothy M. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +183,424 183,424
2020-04-22 Gillheeney Gary S. President and CEO Grant or award +88,181 486,081
2020-04-22 Gillheeney Gary S. President and CEO Grant or award · Stock Option (Right to Buy) +580,842 580,842
2020-04-22 Montecalvo Antonio S. VP Health Policy & Contracting Grant or award +24,134 63,066
2020-04-22 Montecalvo Antonio S. VP Health Policy & Contracting Grant or award · Stock Option (Right to Buy) +158,967 158,967
2020-04-14 Grow Brian Chief Commercial Officer Exercise or conversion +1,150 $1.70 $2K 3,279
2020-04-14 Grow Brian Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) −1,150 1
2020-03-16 Avista Capital Managing Member IV, LLC Director Purchase +75,000 $3.98 $298K 25,517,514
2020-03-13 Avista Capital Managing Member IV, LLC Director Purchase +135,000 $4.31 $581K 25,442,514
2020-03-12 Avista Capital Managing Member IV, LLC Director Purchase +190,887 $3.62 $691K 25,166,052

Page 26 of 32 · 627 trades